GSK plc

GSK plc FCF Yield

The Free Cash Flow Yield of GSK plc (GSK.L) as of Oct 16, 2026 is 6.82 %. In the previous year, Free Cash Flow Yield was 4.09 % — a change of 66.71% (higher).

FCF Yield

6.82 %

YoY

66.71%

Last updated:

Free Cash Flow Yield of GSK plc is 2025 6.82 % . Free Cash Flow Yield of GSK plc was 2024 4.09 % . It decreases by 66.71% higher compared to the previous year.

The GSK plc FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
7.58 GBP
Jan 1, 2019
6.70 GBP
Jan 1, 2020
7.10 GBP
Jan 1, 2021
5.75 GBP
Jan 1, 2022
5.89 GBP
Jan 1, 2023
5.06 GBP
Jan 1, 2024
4.09 GBP
Jan 1, 2025
6.82 GBP
The GSK plc FCF Yield history
YEARFCF YieldYoY
6.82 %+66.71%
4.09 %-19.26%
5.06 %-14.01%
5.89 %+2.47%
5.75 %-19.04%
7.10 %+5.89%
6.70 %-11.59%
7.58 %+40.48%
5.40 %+13.78%
4.75 %+520.51%
0.76 %-80.50%
3.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GSK plc Stock analysis

What does GSK plc do? GSK plc, listed on the London Stock Exchange under the ticker GSK.L, is a pharmaceutical company headquartered in Brentford, United Kingdom. The company, which has been publicly traded since May 22, 1972, operates within the healthcare sector, specifically in the pharmaceuticals industry. GSK employs 94,066 full-time staff, focusing on the research, development, and manufacturing of pharmaceutical medicines, vaccines, and consumer healthcare products. The company's operations are structured around two primary segments: Pharmaceuticals and Vaccines. In the Pharmaceuticals segment, GSK develops and markets medicines for a variety of conditions, including respiratory diseases, HIV and infectious diseases, immuno-inflammation, oncology, and rare diseases. The Vaccines segment provides immunization solutions for all age groups, from infants to the elderly, including pediatric, adolescent, adult, and travel vaccines. GSK's portfolio includes prescription medicines and vaccines, with a particular emphasis on respiratory and HIV-related treatments. The company's business strategy encompasses both innovative therapeutic areas and established product lines, supporting its global presence in healthcare. GSK's official website is www.gsk.com, offering further information about its products and initiatives. GSK plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GSK plc stock

Free Cash Flow Yield of GSK plc is 6.82 % in 2025.

Free Cash Flow Yield of GSK plc changed from 4.09 % to 6.82 %, representing a 66.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield GSK plc since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's GSK plc with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — GSK plc

All Key Metrics — GSK plc